Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Tech And Healthcare ETFs: Are They All That We Have Left?

Published 08/20/2013, 03:10 AM
Updated 03/09/2019, 08:30 AM

On Monday, 8/19/2013, U.S. stocks logged their first 4-day losing streak of the calendar year. Until recently, the idea of a pullback had begun to seem far-fetched. The S&P 500 SPDR Trust (SPY) had been hitting high after record high with remarkable ease. Now the only “rally talk” is centering on how high longer-term bond yields might climb.

The higher the 10-year Treasury yield goes, the lower most market-based securities go. The ugliest falls from grace have occurred in former safe haven segments like REITs, preferred shares and utilities.

Rising Longer-Term Yields Are Killing Most ETFs

Approx

I continue to emphasize that the assets most likely to succeed are those that are less tied to rate sensitivity as well as those that have defensive attributes. For clients, I have maintained an allegiance to exchange-traded vehicles in pharmaceuticals, aerospace and consumer staples sectors. More recently, hedge fund desire for Apple (APPL) ownership has increased the attractiveness of technology ETFs; funds like iShares DJ Technology (IYW) and Vanguard Information Technology (VGT) have some of the highest Apple (APPL) weightings.

Very few investments can thrive in August’s environment of U.S. central bank policy uncertainty. You might even say that we are seeing signs of a mini-panic — a quasi-stampede for the exits of virtually anything with a yield component. Yet the reversal of fortune on Apple (APPL) is certain to buoy technology ETFs.
AAPL
Similarly, First Trust Internet (FDN) may be one of the few funds that is demonstrating three solid months of increasing relative strength against the broader market. Not only is the current price above a 50-day and 200-day trendline, but FDN’s relative strength versus SPY is near a high for 2013.
FDN-SPY

In reality, even tech and health care ETFs will not be able to handle an unchecked rise in longer-term yields. The surprisingly swift run from 1.6% to 2.9% on the 10-year has already decimated investor perception of homebuilding and real estate-related assets; fears of a significant slowdown in consumer spending is another thorn in the bull’s side.

The best moves today? Sell those assets that have been the biggest drag on your portfolio to free up some cash. Use the cash to buy coveted ETFs as the market corrects. That means, continue to favor areas of the market that possess a combination of defensive qualities and limited rate sensitivity.

Disclosure: Gary Gordon, MS, CFP is the president of Pacific Park Financial, Inc., a Registered Investment Adviser with the SEC. Gary Gordon, Pacific Park Financial, Inc, and/or its clients may hold positions in the ETFs, mutual funds, and/or any investment asset mentioned above. The commentary does not constitute individualized investment advice. The opinions offered herein are not personalized recommendations to buy, sell or hold securities. At times, issuers of exchange-traded products compensate Pacific Park Financial, Inc. or its subsidiaries for advertising at the ETF Expert web site. ETF Expert content is created independently of any advertising relationships.


3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.